Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

325

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

325 results for “circulating tumor cells”

Learn how ShareScore rates datasets ↗
zenodo16/100

Dataset related to article "Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer."

<p>PURPOSE:</p> <p>To evaluate the clinical-pathological and prognostic significance of the circulating PD-L1 level in patients with surgically treated NSCLC, by combining data for PD-L1 expression with other immune-related markers and tumor metabolism.</p> <p>METHODS:</p> <p>Overall, 40 patients with resected NSCLC (stage Ia-IIIa) who had preoperative blood storage and underwent staging PET/CT were enrolled for the study. In all cases, we determined plasma levels of PD-L1 (pg/ml), immune-reactive areas (IRA&nbsp;%) covered by CD3, CD68, CD20, CD8, PD-1, and PD-L1 in the tumor specimen, and metabolic parameters on PET, i.e., SUV<sub>max</sub>, SUV<sub>peak</sub>, metabolic tumor volume (MTV), and total lesion glycolysis (TLG). Variables were statistically analyzed to establish their association with disease-free survival (DFS).</p> <p>RESULTS:</p> <p>The circulating levels of PD-L1 in the bloodstream could be determined in 38/40 (95%) samples. The mean and median expression levels were 34.86&nbsp;pg/ml and 24.83&nbsp;pg/ml, respectively. We did not find any statistically significant correlation between circulating PD-L1 and tissue expression of PD-L1/PD-1. Some mild degree of positive correlation was determined between tissue PD-L1 and SUV<sub>max</sub> (&rho;&thinsp;=&amp;thinsp;0.390; p&thinsp;=&amp;thinsp;0.0148). Hierarchical clustering combining circulating, tissue, and metabolic parameters identified clusters with high metabolic tumor burden or high expression of plasma PD-L1 levels (Z score&thinsp;&ge;&thinsp;2) as having a poor DFS (p&thinsp;=&amp;thinsp;0.033). The multivariate analysis detected stage and metabolism (i.e., SUV<sub>max</sub> and SUV<sub>peak</sub>) as independent prognostic factors for DFS.</p> <p>CONCLUSION:</p> <p>Plasma levels of PD-L1 are independent of the expression of PD-1/PD-L1 in NSCLC tumor tissue and, when combined with other clinical-pathological parameters, allow for the identification of clusters with different outcomes.</p>

restrictedMar 2020View details →
geo16/100

EpCAM Based Capture Detects and Recovers Circulating Tumor Cells From Subtypes of Breast Cancer Except Claudin-low

GEO Series GSE71192. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJul 2018View details →
geo12/100

Expression data from human Circulating Tumor Cells (CTC) and HT-29 cells

GEO Series GSE82198. Homo sapiens. 6 samples. Type: Expression profiling by array.

openGEO-OpenJun 2019View details →
zenodo12/100

Dataset related to article "Intrahepatic CD69 + Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression"

<p>This record contains raw data related to article &ldquo;Intrahepatic CD69 + V&delta;1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression&quot;</p> <p>Abstract</p> <p><strong>Background: </strong> More than 50% of all patients with colorectal cancer (CRC) develop liver metastases (CLM), a clinical condition characterized by poor prognosis and lack of reliable prognostic markers. V&delta;1 cells are a subset of tissue-resident gamma delta (&gamma;&delta;) T lymphocytes endowed with a broad array of antitumor functions and showing a natural high tropism for the liver. However, little is known about their impact in the clinical outcomes of CLM.</p> <p><strong>Methods: </strong> We isolated human &gamma;&delta; T cells from peripheral blood (PB) and peritumoral (PT) tissue of 93 patients undergone surgical procedures to remove CLM. The phenotype of freshly purified &gamma;&delta; T cells was assessed by multiparametric flow cytometry, the transcriptional profiles by single cell RNA-sequencing, the functional annotations by Gene Ontology enrichment analyses and the clonotype by &gamma;&delta; T cell receptor (TCR)-sequencing.</p> <p><strong>Results: </strong> The microenvironment of CLM is characterized by a heterogeneous immune infiltrate comprising different subsets of &gamma;&delta; tumor-infiltrating lymphocytes (TILs) able to egress the liver and re-circulate in PB. V&delta;1 T cells represent the largest population of &gamma;&delta; TILs within the PT compartment of CLM that is greatly enriched in V&delta;1 T effector (T<sub>EF</sub>) cells expressing constitutive high levels of CD69. These V&delta;1 CD69<sup>+</sup> TILs express a distinct phenotype and transcriptional signature, show high antitumor potential and correlate with better patient clinical outcomes in terms of lower numbers of liver metastatic lesions and longer overall survival (OS). Moreover, intrahepatic CD69<sup>+</sup> V&delta;1 TILs can egress CLM tissue to re-circulate in PB, where they retain a phenotype, transcriptional signature and TCR clonal repertoires resembling their liver origin. Importantly, even the increased frequencies of the CD69<sup>+</sup> terminally differentiated (T<sub>EMRA</sub>) V&delta;1 cells in PB of patients with CLM significantly correlate with longer OS. The positive prognostic score of high frequencies of CD69<sup>+</sup> T<sub>EMRA</sub> V&delta;1 cells in PB is independent from the neoadjuvant chemotherapy and immunotherapy regimens administered to patients with CLM prior surgery.</p> <p><strong>Conclusions: </strong> The enrichment of tissue-resident CD69<sup>+</sup> V&delta;1 T<sub>EMRA</sub> cells re-circulating at high frequencies in PB of patients with CLM limits tumor progression and represents a new important clinical tool to either predict the natural history of CLM or develop alternative therapeutic protocols of cellular therapies.</p>

restrictedJan 2023View details →
geo12/100

Circulating tumor cell analysis from stage III lung cancer patients

GEO Series GSE249262. Homo sapiens. 76 samples. Type: Expression profiling by array.

openGEO-OpenJan 2024View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record